NO. | YEAR | PHASE | STUDY TYPE | INDICATION |
---|---|---|---|---|
1 | 2022 | Pilot study | Local | COVID-19 치료제 |
2 | 2022 | I/IIa | Local | COVID-19 Vaccine |
3 | 2022 | III | Local | COVID-19 치료제 |
4 | 2022 | III | Global | COVID-19 치료제 |
5 | 2021 | III | Local | COVID-19 치료제 |
6 | 2021 | Consulting | Local | COVID-19 치료제 |
7 | 2021 | II | Local | COVID-19 치료제 |
8 | 2021 | Consulting | Local | COVID-19 치료제 |
9 | 2021 | II | Local | COVID-19 치료제 |
10 | 2021 | II/III | Local | COVID-19 치료제 |
11 | 2021 | III | Global | COVID-19 Vaccine |
12 | 2021 | Consulting | Global | COVID-19 Vaccine |
13 | 2021 | I/IIa | Local | COVID-19 Vaccine |
14 | 2021 | II/III | Global | COVID-19 치료제 |
15 | 2021 | II | Local | COVID-19 치료제 |
16 | 2021 | I/II | Local | COVID-19 치료제 |
17 | 2021 | II | Local | COVID-19 치료제 |
18 | 2021 | III | Local | COVID-19 치료제 |
19 | 2021 | I/IIa | Local | COVID-19 Vaccine |
20 | 2021 | II | Local | COVID-19 치료제 |
21 | 2020 | I/II | Local | COVID-19 Vaccine |
22 | 2020 | I | Local | COVID-19 치료제 |
23 | 2020 | III | Global | COVID-19 Vaccine |
24 | 2020 | II | Local | COVID-19 치료제 |
25 | 2020 | II | Global | COVID-19 치료제 |
26 | 2020 | II | Local | COVID-19 치료제 |
27 | 2020 | II | Local | COVID-19 치료제 |
28 | 2020 | II | Local | COVID-19 치료제 |
29 | 2020 | I/IIa | Local | COVID-19 Vaccine |
30 | 2020 | I/IIa | Local | COVID-19 Vaccine |
31 | 2020 | Medical Device | Local | COVID-19 진단키트 |
32 | 2020 | I/IIa | Local | COVID-19 치료제 |
* LSK Global PS 는 COVID-19 극복을 위해 치료제 개발 22건(Global 3, Local 19), 백신 개발 9건(Global 3, Local 6)과 진단키트 개발 1건의 임상시험을 완료 및 진행하고 있습니다. (2022년 06월 30일 기준)